S&P 및 Nasdaq 내재가치 문의하기

POINT Biopharma Global Inc. PNT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.75
+10%

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 POINT Biopharma Global Inc. (PNT), 포함 25 건 매수21 건 매도. 내부자 매수 총액은 $14.9M 내부자 매도 총액은 $70.58M.

최근 활동이 있는 주요 내부자에는 Silber Allan C, Lubner David Charles, Malik Rajesh. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — PNT

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2023-12-27 Silber Allan C Executive Chairman 주식 반환 537,322 $6.78 $3.64M -
2023-12-27 Lubner David Charles Director 주식 반환 44,749 $9.12 $408.11K -
2023-12-27 Malik Rajesh Director 주식 반환 44,749 $9.12 $408.11K -
2023-12-27 Fleshner Neil E. Chief Medical Officer 주식 반환 84,257 $6.78 $571.26K -
2023-12-27 Demers William L. Chief Financial Officer 주식 반환 131,355 $6.78 $890.59K -
2023-12-27 Goodman Jonathan R. Director 주식 반환 44,749 $9.12 $408.11K -
2023-12-27 Margolin Yael Director 주식 반환 44,749 $9.12 $408.11K -
2023-12-27 Mccann Joe A. Chief Executive Officer 주식 반환 692,643 $6.78 $4.7M -
2023-12-27 Hogue Gerald L. Director 주식 반환 44,749 $9.12 $408.11K -
2023-12-27 Jensen Jessica D. EVP Clinical Development 주식 반환 136,055 $6.78 $922.45K -
2023-12-27 Kelly Justyna Chief Operating Officer 주식 반환 98,358 $6.78 $666.87K -
2023-12-26 Lubner David Charles Director 공개매수 (매도) 35,400 $12.50 $442.5K 3,600
2023-12-26 Malik Rajesh Director 공개매수 (매도) 3,700 $12.50 $46.25K -
2023-12-26 Goodman Jonathan R. Director 공개매수 (매도) 41,872 $12.50 $523.4K -
2023-12-26 Hogue Gerald L. Director 공개매수 (매도) 21,596 $12.50 $269.95K -
2023-12-22 Silber Allan C Executive Chairman 공개매수 (매도) 71,744 $12.50 $896.8K -
2023-12-22 Fleshner Neil E. Chief Medical Officer 공개매수 (매도) 358 $12.50 $4.48K -
2023-12-22 Mccann Joe A. Chief Executive Officer 공개매수 (매도) 3,494,153 $12.50 $43.68M -
2023-12-18 Bvf Partners L P/il Officer 정보 매도 896,366 $12.45 $11.16M -
2023-11-06 Mccann Joe A. Chief Executive Officer 증여 (지급) 120,000 - - 3,494,153
2023-11-03 Silber Allan C Executive Chairman 증여 (지급) 500,000 - - 38,087
2023-11-02 Bvf Partners L P/il 10 Percent Owner 처분 - - - 896,366
2023-10-31 Fleshner Neil E. Chief Medical Officer 증여 (지급) 250,000 - - 2,773,045
2023-06-13 Martell Bridget A Director RSU 부여 80,503 $10.08 $811.47K 80,503
2023-06-12 Martell Bridget A Director 알 수 없음 - - - -
2023-06-01 Lubner David Charles Director RSU 부여 44,749 $9.12 $408.11K 44,749
2023-06-01 Malik Rajesh Director RSU 부여 44,749 $9.12 $408.11K 44,749
2023-06-01 Goodman Jonathan R. Director RSU 부여 44,749 $9.12 $408.11K 44,749
2023-06-01 Margolin Yael Director RSU 부여 44,749 $9.12 $408.11K 44,749
2023-06-01 Hogue Gerald L. Director RSU 부여 44,749 $9.12 $408.11K 44,749
2023-03-28 Silber Allan C 10 Percent Owner, Officer: Executive Chairman RSU 부여 537,322 $6.78 $3.64M 537,322
2023-03-28 Fleshner Neil E. Chief Medical Officer RSU 부여 84,257 $6.78 $571.26K 84,257
2023-03-28 Demers William L. Chief Financial Officer RSU 부여 131,355 $6.78 $890.59K 131,355
2023-03-28 Mccann Joe A. Chief Executive Officer RSU 부여 692,643 $6.78 $4.7M 692,643
2023-03-28 Jensen Jessica D. EVP Clinical Development RSU 부여 136,055 $6.78 $922.45K 136,055
2023-03-28 Kelly Justyna Chief Operating Officer RSU 부여 98,358 $6.78 $666.87K 98,358
2023-03-21 Hogue Gerald L. Director 옵션 행사 (매도) 17,936 $6.97 $125.01K 17,936
2022-11-29 Mccann Joe A. Chief Executive Officer 정보 매수 2,160 $6.64 $14.34K 3,616,313
2022-11-28 Malik Rajesh Director 정보 매수 3,700 $6.66 $24.64K 3,700
2022-11-25 Hogue Gerald L. Director 정보 매수 3,660 $6.82 $24.94K 3,660
2022-11-23 Lubner David Charles Director 정보 매수 3,600 $6.85 $24.66K 3,600
2022-11-21 Margolin Yael Director 정보 매수 1,710 $6.56 $11.22K 1,710
2022-11-18 Silber Allan C Executive Chairman 정보 매수 22,397 $6.50 $145.58K 4,268,605
2022-11-18 Goodman Jonathan R. Director 정보 매수 6,000 $6.33 $37.98K 41,872
2022-11-17 Silber Allan C Executive Chairman 정보 매수 27,603 $6.00 $165.62K 4,246,208
2022-06-02 Lubner David Charles Director RSU 부여 25,614 $8.31 $212.85K 25,614
2022-06-02 Malik Rajesh Director RSU 부여 25,614 - - 25,614
2022-06-02 Goodman Jonathan R. Director RSU 부여 25,614 - - 25,614
2022-06-02 Margolin Yael Director RSU 부여 25,614 - - 25,614
2022-06-02 Hogue Gerald L. Director RSU 부여 25,614 - - 25,614
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기